Literature DB >> 28546157

Erratum for the Research Article "Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15" by T. Han, M. Goralski, N. Gaskill, E. Capota, J. Kim, T. C. Ting, Y. Xie, N. S. Williams, D. Nijhawan.

.   

Abstract

Entities:  

Year:  2017        PMID： 28546157     DOI： 10.1126/science.aan7977

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

Review 1.  Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features.

Authors:  Valeria Visconte; Megan O Nakashima; Heesun J Rogers
Journal:  Cancers (Basel)       Date:  2019-11-22       Impact factor: 6.639

2.  Prediction of potential inhibitors of SARS-CoV-2 using 3D-QSAR, molecular docking modeling and ADMET properties.

Authors:  Ayoub Khaldan; Soukaina Bouamrane; Fatima En-Nahli; Reda El-Mernissi; Khalil El Khatabi; Rachid Hmamouchi; Hamid Maghat; Mohammed Aziz Ajana; Abdelouahid Sbai; Mohammed Bouachrine; Tahar Lakhlifi
Journal:  Heliyon       Date:  2021-03-26

Review 3.  Major Advances in Targeted Protein Degradation: PROTACs, LYTACs, and MADTACs.

Authors:  Shanique Alabi; Craig Crews
Journal:  J Biol Chem       Date:  2021-04-08       Impact factor: 5.157

4.  Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models.

Authors:  Shivendra Singh; Waise Quarni; Maria Goralski; Shibiao Wan; Hongjian Jin; Lee-Ann Van de Velde; Jie Fang; Qiong Wu; Ahmed Abu-Zaid; Tingting Wang; Ravi Singh; David Craft; Yiping Fan; Thomas Confer; Melissa Johnson; Walter J Akers; Ruoning Wang; Peter J Murray; Paul G Thomas; Deepak Nijhawan; Andrew M Davidoff; Jun Yang
Journal:  Sci Adv       Date:  2021-11-17       Impact factor: 14.136
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.